Comparative Cost-Benefit Analyses of Paricalcitol and Calcitriol in Stage 4 Chronic Kidney Disease from the Perspective of a Health Plan.
| Autor: | Gal-Moscovici, Anca1,2, Sprague, Stuart M.3 ssprague@northwestern.edu |
|---|---|
| Zdroj: | Clinical Drug Investigation. 2007, Vol. 27 Issue 2, p105-113. 9p. 9 Charts. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|